![Local hair-loss biotech RepliCel completes $4.2m deal with cosmetics giant - Technology | Business in Vancouver Local hair-loss biotech RepliCel completes $4.2m deal with cosmetics giant - Technology | Business in Vancouver](https://biv.com/sites/default/files/styles/media_image/public/2017-12/gv_20130715_biv0112_130719968.jpg?itok=vmy9Sjgm)
Local hair-loss biotech RepliCel completes $4.2m deal with cosmetics giant - Technology | Business in Vancouver
RepliCel Life Sciences Inc. met fin au contrat de licence avec Shiseido -Le 21 décembre 2021 à 17:14 | Zonebourse
![REPLICEL RCH-01 HAIR LOSS TREATMENT **TERMINATES** LICENSE AGREEMENT WITH SHISEIDO. F&*K!! - YouTube REPLICEL RCH-01 HAIR LOSS TREATMENT **TERMINATES** LICENSE AGREEMENT WITH SHISEIDO. F&*K!! - YouTube](https://i.ytimg.com/vi/q4iKYaW3ObE/maxresdefault.jpg)
REPLICEL RCH-01 HAIR LOSS TREATMENT **TERMINATES** LICENSE AGREEMENT WITH SHISEIDO. F&*K!! - YouTube
RepliCel Life Sciences Inc. - RepliCel offers positive news in troubled times. https://zcu.io/zM4H | Facebook
Q: When will RCH-01 be commercially available? | CEO Lee Buckler answers the often asked question, "When will RCH-01 be commercially available?" | By RepliCel Life Sciences Inc. | Hi, I'm CEO
RepliCel Life Sciences Inc. - We're expecting data from the Japanese clinical research from Shiseido later this year. In the meantime, visit our website to learn more about hair regeneration: http://bit.ly/2n6vFBt
![Rch-01 Launching Time | Rch-01 in India | Rch-01 for Hairloss, Baldness | Rch-01 Results | Replicel - YouTube Rch-01 Launching Time | Rch-01 in India | Rch-01 for Hairloss, Baldness | Rch-01 Results | Replicel - YouTube](https://i.ytimg.com/vi/b1_2n3eReSQ/hqdefault.jpg)
Rch-01 Launching Time | Rch-01 in India | Rch-01 for Hairloss, Baldness | Rch-01 Results | Replicel - YouTube
Q: When will RCH-01 be commercially available? | CEO Lee Buckler answers the often asked question, "When will RCH-01 be commercially available?" | By RepliCel Life Sciences Inc. | Hi, I'm CEO
![Positive Results from RepliCel's RCS-01 Phase I Skin Trial are the Company's Most Compelling to Date Positive Results from RepliCel's RCS-01 Phase I Skin Trial are the Company's Most Compelling to Date](https://www.sec.gov/Archives/edgar/data/1205059/000127956917000691/image_002.jpg)